News

UCSF Benioff Children’s Hospitals Excel in Pediatric Specialties

UCSF Benioff Children’s Hospitals Excel in Pediatric Specialties

June 21, 2016

UCSF Benioff Children’s Hospitals have placed among the nation’s premier children’s hospitals in all 10 pediatric specialties. The hospitals ranked among the top 25 in eight of the 10 specialties and were best in the Bay Area in five practices – cancer, diabetes and endocrinology, neonatology, neurology and neurosurgery, and urology – according to U.S. News & World Report, which released the results of its best pediatric hospitals on June 21, 2016.

UCSF Researcher Part of Consortium Awarded $7.5M to Evaluate Breast Imaging Strategies

UCSF Researcher Part of Consortium Awarded $7.5M to Evaluate Breast Imaging Strategies

June 6, 2016

Karla Kerlikowske, MD, a co-principal investigator of the Breast Cancer Surveillance Consortium(BCSC), is part of the team awarded $7.5 million by the Patient-Centered Outcomes Research Institute(PCORI) board of governors to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies.

Developments in Cancer Research and Care, from Prostate Cancer to Breast Cancer to Immunotherapy

Developments in Cancer Research and Care, from Prostate Cancer to Breast Cancer to Immunotherapy

June 1, 2016

Cancer specialists from UC San Francisco will share information on advances in research during the annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s most prestigious gatherings of oncology professionals.

A Slight Increase in Pediatric Cancer Risk Seen with Infant Phototherapy

A Slight Increase in Pediatric Cancer Risk Seen with Infant Phototherapy

May 22, 2016

Phototherapy, increasingly used to treat jaundiced infants, could very slightly raise the risk of pediatric cancers, particularly myeloid leukemia, according to epidemiological research published online on May 23 in Pediatrics.

Better Survival for Colon Cancer Patients with Left-Sided Tumors

Better Survival for Colon Cancer Patients with Left-Sided Tumors

May 18, 2016

The chances of surviving colon cancer could depend on which side of the colon the cancer strikes.

Hybrid Cancer Drug Could Be Resistance-Resistant

Hybrid Cancer Drug Could Be Resistance-Resistant

May 18, 2016

A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outsmart drug-resistant cancers.

Trever Bivona, Pamela Ling Elected to American Society for Clinical Investigation

Trever Bivona, Pamela Ling Elected to American Society for Clinical Investigation

April 28, 2016

Five UC San Francisco faculty members have been elected to the American Society for Clinical Investigation (ASCI) after a highly competitive nomination process. The ASCI, which is one of the oldest medical honor societies in the United States, received 160 membership nominations for 2016 and ...
Laura Esserman Named to TIME 100 List of Most Influential People in the World

Laura Esserman Named to TIME 100 List of Most Influential People in the World

April 21, 2016

Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

New UCSF Center for BRCA Research Expands Care for Increased Cancer Risk

New UCSF Center for BRCA Research Expands Care for Increased Cancer Risk

April 19, 2016

As more people get their hands on their own genetic data each day, many face an increasingly common question: What do you do if you carry a genetic risk factor for cancer?

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

April 18, 2016

Martin Kampmann, PhD, Assistant Professor at the Institute for Neurodegenerative Diseases, UCSF, receives $750,000 research award for his project, "'Weak links' in cancer proteostasis networks as new therapeutic targets."